CTOs on the Move

Establishment Labs

www.establishmentlabs.com

 
Establishment Labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. With more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for Establishment Labs` founders and top executives. As a result, Motiva Implants® has established a level of product innovation that always results in safety. And while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. ...
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Establishment Labs raised $55M on 08/28/2017

Similar Companies

Allied Healthcare Products

Allied Healthcare Products, Inc. (Allied) manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate site settings, including sub-acute care facilities, home healthcare and emergency medical care

CIMIT -Center for integration of medicine and innovative technology

CIMIT -Center for integration of medicine and innovative technology is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Work Health Solutions

On-site health services for employers nation wide. Work Health Solutions keep workplaces safe and OSHA-compliant by offering onsite medical surveillance testing and occupational medical exams. In addition we also offer customized programs to meet your on-site medical needs. Wellness clinics, primary care, preventative program and full occupational health services.

Modulim

Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, improve outcomes and reduce costs across the continuum of care by enabling early detection and intervention. Clarifi is affordable and easily integrated into a clinician`s practice. Clarifi imaging is supported by reimbursement (Current Procedural Terminology (CPT®) Proprietary Laboratory Analyses (PLA) code (0061U). Our proprietary technology - SFDI - was invented by Modulim`s founder and CTO David Cuccia, Ph.D., and his colleagues at UC Irvine`s Beckman Laser Institute. SFDI is a noninvasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin. This unique technology deciphers the reflection, absorbance, and scattering of light in tissue. Both David and Amaan Mazhar, Ph.D., Modulim`s VP of Research & Development, are both internationally-recognized experts in the field of medical photonics. #seebeyond

Nevro

Nevro`s Senza system is the only SCS system capable of delivering HF10™ therapy and providing pain relief without paresthesia.